220 related articles for article (PubMed ID: 27114459)
21. Calreticulin mutants in mice induce an MPL-dependent thrombocytosis with frequent progression to myelofibrosis.
Marty C; Pecquet C; Nivarthi H; El-Khoury M; Chachoua I; Tulliez M; Villeval JL; Raslova H; Kralovics R; Constantinescu SN; Plo I; Vainchenker W
Blood; 2016 Mar; 127(10):1317-24. PubMed ID: 26608331
[TBL] [Abstract][Full Text] [Related]
22. Allogenic hematopoietic stem cell as curative treatment in myelofibrosis.
Wardhana ; Datau EA; Rotty LW; Haroen H
Acta Med Indones; 2011 Oct; 43(4):252-9. PubMed ID: 22156358
[TBL] [Abstract][Full Text] [Related]
23. CD109 is expressed on a subpopulation of CD34+ cells enriched in hematopoietic stem and progenitor cells.
Murray LJ; Bruno E; Uchida N; Hoffman R; Nayar R; Yeo EL; Schuh AC; Sutherland DR
Exp Hematol; 1999 Aug; 27(8):1282-94. PubMed ID: 10428505
[TBL] [Abstract][Full Text] [Related]
24. Crucial factors of the inflammatory microenvironment (IL-1β/TNF-α/TIMP-1) promote the maintenance of the malignant hemopoietic clone of myelofibrosis: an in vitro study.
Sollazzo D; Forte D; Polverelli N; Romano M; Perricone M; Rossi L; Ottaviani E; Luatti S; Martinelli G; Vianelli N; Cavo M; Palandri F; Catani L
Oncotarget; 2016 Jul; 7(28):43974-43988. PubMed ID: 27304059
[TBL] [Abstract][Full Text] [Related]
25. Behavior of CD34+ cells isolated from patients with polycythemia vera in NOD/SCID mice.
Ishii T; Zhao Y; Sozer S; Shi J; Zhang W; Hoffman R; Xu M
Exp Hematol; 2007 Nov; 35(11):1633-40. PubMed ID: 17764815
[TBL] [Abstract][Full Text] [Related]
26. CD34 Antigen and the MPL Receptor Expression Defines a Novel Class of Human Cord Blood-Derived Primitive Hematopoietic Stem Cells.
Matsuoka Y; Takahashi M; Sumide K; Kawamura H; Nakatsuka R; Fujioka T; Sonoda Y
Cell Transplant; 2017 Jun; 26(6):1043-1058. PubMed ID: 27938494
[TBL] [Abstract][Full Text] [Related]
27. JAK2 and MPL protein levels determine TPO-induced megakaryocyte proliferation vs differentiation.
Besancenot R; Roos-Weil D; Tonetti C; Abdelouahab H; Lacout C; Pasquier F; Willekens C; Rameau P; Lecluse Y; Micol JB; Constantinescu SN; Vainchenker W; Solary E; Giraudier S
Blood; 2014 Sep; 124(13):2104-15. PubMed ID: 25143485
[TBL] [Abstract][Full Text] [Related]
28. Simultaneous measurement of serum thrombopoietin and expression of megakaryocyte c-Mpl with clinical and laboratory correlates for myelofibrosis with myeloid metaplasia.
Elliot MA; Yoon SY; Kao P; Li CY; Tefferi A
Eur J Haematol; 2002 Mar; 68(3):175-9. PubMed ID: 12068799
[TBL] [Abstract][Full Text] [Related]
29. Circulating Cd34+ cell count differentiates primary myelofibrosis from other Philadelphia-negative myeloproliferative neoplasms: a pragmatic study.
Orvain C; Luque Paz D; Dobo I; Cottin L; Le Calvez G; Chauveau A; Mercier M; Farhi J; Boyer F; Ianotto JC; Guibourg B; Rousselet MC; Zandecki M; Ifrah N; Hunault-Berger M; Ugo V; Genevieve F
Ann Hematol; 2016 Oct; 95(11):1819-23. PubMed ID: 27582015
[TBL] [Abstract][Full Text] [Related]
30. Thrombopoietin and hematopoietic stem cells.
de Graaf CA; Metcalf D
Cell Cycle; 2011 May; 10(10):1582-9. PubMed ID: 21478671
[TBL] [Abstract][Full Text] [Related]
31. Megakaryocyte progenitors derived from bone marrow or G-CSF-mobilized peripheral blood CD34 cells show a distinct phenotype and responsiveness to interleukin-3 (IL-3) and PEG-recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF).
Catani L; Gugliotta L; Campanini E; Mangianti S; Gibellini D; Baravelli S; Vianelli N; Lemoli RM; Tura S
Br J Haematol; 1998 Jan; 100(1):207-18. PubMed ID: 9450813
[TBL] [Abstract][Full Text] [Related]
32. Thrombopoietin mobilizes CD34+ cell subsets into peripheral blood and expands multilineage progenitors in bone marrow of cancer patients with normal hematopoiesis.
Murray LJ; Luens KM; Estrada MF; Bruno E; Hoffman R; Cohen RL; Ashby MA; Vadhan-Raj S
Exp Hematol; 1998 Mar; 26(3):207-16. PubMed ID: 9502616
[TBL] [Abstract][Full Text] [Related]
33. Thrombopoietin, but not cytokines binding to gp130 protein-coupled receptors, activates MAPKp42/44, AKT, and STAT proteins in normal human CD34+ cells, megakaryocytes, and platelets.
Majka M; Ratajczak J; Villaire G; Kubiczek K; Marquez LA; Janowska-Wieczorek A; Ratajczak MZ
Exp Hematol; 2002 Jul; 30(7):751-60. PubMed ID: 12135673
[TBL] [Abstract][Full Text] [Related]
34. The thrombopoietin receptor, MPL, is critical for development of a JAK2V617F-induced myeloproliferative neoplasm.
Sangkhae V; Etheridge SL; Kaushansky K; Hitchcock IS
Blood; 2014 Dec; 124(26):3956-63. PubMed ID: 25339357
[TBL] [Abstract][Full Text] [Related]
35. miR-28 is a thrombopoietin receptor targeting microRNA detected in a fraction of myeloproliferative neoplasm patient platelets.
Girardot M; Pecquet C; Boukour S; Knoops L; Ferrant A; Vainchenker W; Giraudier S; Constantinescu SN
Blood; 2010 Jul; 116(3):437-45. PubMed ID: 20445018
[TBL] [Abstract][Full Text] [Related]
36. Hierarchical structure of human megakaryocyte progenitor cells.
Hoffman R; Murrav LJ; Young JC; Luens KM; Bruno E
Stem Cells; 1996; 14 Suppl 1():75-81. PubMed ID: 11012205
[TBL] [Abstract][Full Text] [Related]
37. Effects of chromatin-modifying agents on CD34+ cells from patients with idiopathic myelofibrosis.
Shi J; Zhao Y; Ishii T; Hu W; Sozer S; Zhang W; Bruno E; Lindgren V; Xu M; Hoffman R
Cancer Res; 2007 Jul; 67(13):6417-24. PubMed ID: 17616702
[TBL] [Abstract][Full Text] [Related]
38. Fetal bone marrow CD34+CD41+ cells are enriched for multipotent hematopoietic progenitors, but not for pluripotent stem cells.
Murray LJ; Mandich D; Bruno E; DiGiusto RK; Fu WC; Sutherland DR; Hoffman R; Tsukamoto A
Exp Hematol; 1996 Feb; 24(2):236-45. PubMed ID: 8641347
[TBL] [Abstract][Full Text] [Related]
39. Phenotypic characterization of malignant progenitor cells in patients with idiopathic myelofibrosis.
Bao Y; Hu W; Guo Y; Yang W
Hematol Oncol Stem Cell Ther; 2019 Sep; 12(3):146-154. PubMed ID: 30796884
[TBL] [Abstract][Full Text] [Related]
40. Targeting c-Mpl for revival of human immunodeficiency virus type 1-induced hematopoietic inhibition when CD34+ progenitor cells are re-engrafted into a fresh stromal microenvironment in vivo.
Koka PS; Kitchen CM; Reddy ST
J Virol; 2004 Oct; 78(20):11385-92. PubMed ID: 15452260
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]